Values, preferences and burden of treatment for the initiation of GLP-1 receptor agonists and SGLT-2 inhibitors in adult patients with type 2 diabetes: a systematic review

by Per Olav Vandvik, Qiukui Hao, Lyubov Lytvyn, Sheyu Li, Jose Gerardo González-González, Rene Rodriguez-Gutierrez, Suetonia C Palmer, Reem A Mustafa, Ricardo Cesar Solis, Alejandro Díaz González-Colmenero, Juan Manuel Millán-Alanís, Neri Alejandro Alvarez-Villalobos
Published 2021-07-01